These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7251159)

  • 21. Extracellular polysaccharides of Actinomyces viscosus.
    Rosan B; Hammond BF
    Infect Immun; 1974 Aug; 10(2):304-8. PubMed ID: 4851986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation of sucrose by whole cells and plaque of Actinomyces naeslundii.
    Miller CH
    Infect Immun; 1974 Dec; 10(6):1280-91. PubMed ID: 4611924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of iron limitation on slime production by Staphylococcus aureus.
    Baldassarri L; Bertuccini L; Ammendolia MG; Arciola CR; Montanaro L
    Eur J Clin Microbiol Infect Dis; 2001 May; 20(5):343-5. PubMed ID: 11453596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of fluoride, lithium and strontium on extracellular polysaccharide production by Streptococcus mutans and Actinomyces viscosus.
    Treasure P
    J Dent Res; 1981 Aug; 60 Spec No C():1601-10. PubMed ID: 6455453
    [No Abstract]   [Full Text] [Related]  

  • 25. Surface localization of sialic acid on Actinomyces viscosus.
    Jones AH; Lee CC; Moncla BJ; Robinovitch MR; Birdsell DC
    J Gen Microbiol; 1986 Dec; 132(12):3381-91. PubMed ID: 3655719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chemically defined medium for slime production by coagulase-negative staphylococci.
    Hussain M; Hastings JG; White PJ
    J Med Microbiol; 1991 Mar; 34(3):143-7. PubMed ID: 2010904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological, chemical, and antigenic characterization of cell walls of the oral pathogenic strains Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1980; 25(7):451-7. PubMed ID: 6935993
    [No Abstract]   [Full Text] [Related]  

  • 28. A polysaccharide from Streptococcus sanguis 34 that inhibits coaggregation of S. sanguis 34 with Actinomyces viscosus T14V.
    McIntire FC; Crosby LK; Vatter AE; Cisar JO; McNeil MR; Bush CA; Tjoa SS; Fennessey PV
    J Bacteriol; 1988 May; 170(5):2229-35. PubMed ID: 3360742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.
    Christensen GD; Simpson WA; Bisno AL; Beachey EH
    Infect Immun; 1982 Jul; 37(1):318-26. PubMed ID: 6179880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of intracellular polysaccharide from Actinomyces viscosus.
    Komiyama K; Duncan D; Singer DL; Khandelwal RL
    Caries Res; 1983; 17(1):59-61. PubMed ID: 6571808
    [No Abstract]   [Full Text] [Related]  

  • 31. Composition of Pseudomonas aeruginosa slime.
    Brown MR; Foster JH; Clamp JR
    Biochem J; 1969 May; 112(4):521-5. PubMed ID: 4240755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of inflammatory cells and oral microorganisms. VII. In vitro polymorphonuclear responses to viable bacteria and to subcellular components of avirulent and virulent strains of Actinomyces viscosus.
    Taichman NS; Hammond BF; Tsai CC; Baehni PC; McArthur WP
    Infect Immun; 1978 Aug; 21(2):594-604. PubMed ID: 689737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Qureshi JV; Gibbons RJ
    Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface fibrils (fimbriae) of Actinomyces viscosus T14V.
    Cisar JO; Vatter AE
    Infect Immun; 1979 May; 24(2):523-31. PubMed ID: 88416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological, chemical and antigenic characterization of M-1 N-acetylmuramidase-digested cell walls of the oral pathogenic bacterium Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1982; 27(3):183-91. PubMed ID: 6953934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial products in utilization of sucrose by Actinomyces viscosus.
    Suginaka H; Wada H; Kotani S
    Biken J; 1975 Dec; 18(4):271-4. PubMed ID: 1218076
    [No Abstract]   [Full Text] [Related]  

  • 37. Construction and use of integration plasmids to generate site-specific mutations in the Actinomyces viscosus T14V chromosome.
    Yeung MK
    Infect Immun; 1995 Aug; 63(8):2924-30. PubMed ID: 7622214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds.
    McIntire FC; Crosby LK; Vatter AE
    Infect Immun; 1982 Apr; 36(1):371-8. PubMed ID: 7076303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of extracellular polysaccharide matrix by Zoogloea ramigera.
    Parsons AB; Dugan PR
    Appl Microbiol; 1971 Apr; 21(4):657-61. PubMed ID: 5575568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.